API
Guaiacol (≥98%) – 50 mg vial
EGP2,394.00
| Product Name | Guaiacol analytical standard |
| Synonym | Catechol monomethyl ether, 2-Methoxyphenol, Pyrocatechol monomethyl ether |
| Product Nawah code | AMMS22514 |
| CAS number | 90-05-1 |
| Empirical Formula | C7H8O2 |
| Molecular weight | 124.11g/mol |
| PubChem Substance ID | 460 |
| Storage temperature | 2-8 oC |
| Physical appearance | Viscous colourless liquid |
| Purity | ≥98% |
| Disclaimer | The producer certifies that this reference material meets the specification stated in its certificate until the expiry date, provided it is stored unopened at the recommended temperature herein. |
|
|
Guaifenesin (≥98%)
EGP3,591.00 – EGP6,042.00
| Product Name | Guaifenesin analytical standard |
| Synonym | 3-(o-Methoxyphenoxy)-1,2-propanediol, Guaifenesin, Guaiacol glyceryl ether, Glycerol guaiacolate |
| Product Nawah code | AMAY22034 |
| CAS number | 93-14-1 |
| Empirical Formula | C10H14O4 |
| Molecular weight | 198.22g/mol |
| PubChem Substance ID | 3516 |
| Storage temperature | 2-8 oC |
| Physical appearance | White powder |
| Purity | ≥98% |
| Disclaimer | The producer certifies that this reference material meets the specification stated in its certificate until the expiry date, provided it is stored unopened at the recommended temperature herein. |
|
|
Hydrochlorothiazide (≥98%)
EGP1,482.00 – EGP2,508.00| Product Name | Hydrochlorothiazide analytical standards |
| Synonym | 6-chloro-1,1-dioxo-3,4-dihydro-2H-1λ6,2,4-benzothiadiazine-7-sulfonamide |
| Product Nawah code | AMMA22084 |
| CAS number | 58-93-5 |
| Empirical Formula | C7H8ClN3O4S2 |
| Molecular weight | 297.74 g/mol |
| PubChem Substance ID | 3639 |
| Storage temperature | 2-8 oC |
| Physical appearance | White powder |
| Purity (HPLC area% normalized) | ≥98% |
Ibuprofen (≥98%)
EGP1,995.00 – EGP2,964.00 / vial| Product Name | Ibuprofen analytical standard |
| Synonym | α-Methyl-4-(isobutyl)phenylacetic acid |
| Product Nawah code | AMMO221015 |
| CAS number | 15687-27-1 |
| Empirical Formula | C13H18O2 |
| Molecular weight | 206.28 g/mol |
| PubChem Substance ID | 3672 |
| Storage temperature | 2-8 oC |
| Physical appearance | White Powder |
| Purity (HPLC area% normalized) |
≥98% |
Ivabradine HCl (≥98%) – 25 mg vial
EGP7,011.00 / vial| Product Name | Ivabradine HCl analytical standard |
| Synonym | 3-[3-[[[(7S)-3,4-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-2H-3-benzazepin-2-one hydrochloride |
| Product Nawah code | AMAA23415 |
| CAS number | 148849-67-6 |
| Empirical Formula | C27H36N2O5.HCl |
| Molecular weight | 505.06 g/mol |
| PubChem Substance ID | 3045381 |
| Storage temperature | 2-8 oC |
| Physical appearance | White Powder |
| Purity (HPLC area% normalized) | ≥98% |
Ketoprofen (≥98%)
EGP4,560.00 – EGP7,011.00 / vial| Product Name | Ketoprofen analytical standard |
| Synonym | 2-(3-Benzoylphenyl)propionic acid |
| Product Nawah code | AMAA23416 |
| CAS number | 22071-15-4 |
| Empirical Formula | C16H14O3 |
| Molecular weight | 254.28 g/mol |
| PubChem Substance ID | 3825 |
| Storage temperature | 2-8 oC |
| Physical appearance | White Crystals |
| Purity (HPLC area% normalized) | ≥98% |
Lacosamide (≥98%) – 50 mg vial
EGP5,985.00 / vial| Product Name | Lacosamide |
| Synonym | (R)-2-acetamido-N-benzyl-3-methoxypropanamide |
| Product Nawah code | AMAA23417 |
| CAS number | 175481-36-4 |
| Empirical Formula | C13H18N2O3 |
| Molecular weight | 250.29 g/mol |
| PubChem Substance ID | 219078 |
| Storage temperature | 2-8 oC |
| Physical appearance | White powder |
| Purity (HPLC area% normalized) | ≥98% |
Levofloxacin Hemihydrate (≥98%) – 100 mg vial
EGP4,959.00 / vial| Product Name | Levofloxacin Hemihydrate |
| Synonym | (-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid Hemihydrate; Dynaquin; Levofloxacin Hydrate; |
| Product Nawah code | AMAA23418 |
| CAS number | 138199-71-0 |
| Empirical Formula | C18H20FN3O4. ½ H2O |
| Molecular weight | 361.37 + 18 (1/2 H2O) g/mol (740.75) |
| PubChem Substance ID | 3033924 |
| Storage temperature | -20 oC |
| Physical appearance | Pale yellow to light yellow solid |
| Purity (HPLC area% normalized) | ≥98% |
Lidocaine free base (≥98%)
EGP1,710.00 – EGP2,400.00 / vial| Product Name | Lidocaine analytical standard |
| Synonym | 2-Diethylamino-N-(2,6-dimethylphenyl)acetamide |
| Product Nawah code | AMMA220816 |
| CAS number | 137-58-6 |
| Empirical Formula | C14H22N2O |
| Molecular weight | 234.34 g/mol |
| PubChem Substance ID | 3676 |
| Storage temperature | 2-8 oC |
| Physical appearance | White crystals |
| Purity (HPLC area% normalized) |
≥98% |
| Disclaimer | The producer certifies that this reference material meets the specification stated in its certificate until the expiry date, provided it is stored unopened at the recommended temperature herein. |
Lidocaine Hydrochloride Monohydrate (≥98%)
EGP1,710.00 – EGP2,400.00 / vial| Product Name | Lidocaine HCl monohydrate analytical standard |
| Synonym | 2-Diethylamino-N-(2,6-dimethylphenyl)acetamide hydrochloride monohydrate |
| Product Nawah code | AMMA220817 |
| CAS number | 6108-05-0 |
| Empirical Formula | C14H22N2 O.HCI H2O |
| Molecular weight | 288.81 g/mol |
| PubChem Substance ID | 16219577 |
| Storage temperature | 2-8 oC , Dark |
| Physical appearance | White crystals |
| Purity (HPLC area% normalized) |
≥98% |
| Disclaimer | The producer certifies that this reference material meets the specification stated in its certificate until the expiry date, provided it is stored unopened at the recommended temperature herein. |
Linagliptin (≥98%)
EGP2,394.00 – EGP4,332.00 / vial
| Product Name | Linagliptin analytical standard |
| Synonym | Tradjenta, B1 1356BS, 8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione |
| Product Nawah code | AMAH21124 |
| CAS number | 668270-12-0 |
| Empirical Formula | C25H28N8O2 |
| Molecular weight | 472.54g/mol |
| PubChem Substance ID | 10096344 |
| Storage temperature | 2-8 oC , Dark |
| Physical appearance | White powder |
| Purity | ≥98% |
| Description | Linagliptin is indicated for the treatment of type II diabetes in addition to diet and exercise |
| Related literature | DrugBank: URL: https://www.drugbank.ca/drugs/DB08882
|
Linezolid (≥98%) – 50 mg vial
EGP4,500.00 / vial| Product Name | Linezolid analytical standard |
| Synonym | N-[[(5S)-3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide, |
| Product Nawah code | AMAY24602 |
| CAS number | 165800-03-3 |
| Empirical Formula | C16H20FN3O4 |
| Molecular weight | 337.35 g/mol |
| PubChem Substance ID | 441401 |
| Storage temperature | 2-8 oC |
| Physical appearance | White to off-white powder |
| Purity (HPLC area% normalized) | ≥98% |